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effectweness estimating by continuous 12.lead electrocardiographic analysis (12L-ECG). 
Methods: Out of 157 consecutive pts who presented in the first 6 hours of STEMI were 
studied The course of higher ST-segment elevation was evaluated by continuous lZL- 
ECG monitoring. Successful IT was considered as the abrupt 50% ST stable recovery in 
the first 90 mnts after IT Initiation. The studied markers were estimated upon admission. 
Results: Seventy-nine patients had positive (>O.lng/L) cTnl. There was a significant 
relationship between cTnl and prehospital delay (time interval from Index pam to admis- 
sion)(Spearman R=OSl; p<O.OOl) Patients wth or without positive cTnl didn’t differ in 
either hs-CRP (0.58mg/dl vs.O.Mmg/dl respectively; p=O.65), Lp(a) (25.7mg/dl 
vs.26.3mg/dl respectwely; p=O.74), or Fb (3.4glL vs.3.3g/L respectively; p=O.85). In the 
first 90 mm 85 (851157; 54.1%) patients had attained 50% ST recovery. By univariate 
logistic wgrewon analysis cTnl (RR=0.44, p=O.OOl), time interval from index pain to 
thrombolysis Initiation (R&0.88; pcO.OOl), hs-CRP (R&0.74; pcO.OOl), and diabetes 
mellitus (RR=0.27; p=O.OOl) were related to IT effectiveness. Fb or Lp(a) were not (p=NS 
for both). By multivanate analysis time Interval from index pain to IT initiation (R&0.54; 
pcO.001). hs-CRP (R&0.66; p=O.Ol), and diabetes mellitus (RR=0.30; p=O.OOS) were 
the only independent predictors of IT outcome. 
N: Total number of patients in each group; n: number of events; HR: hazard ratio; Cl: 
confidence interval; *Primary efficacy endpoint of ASSENT-3: 30.day mortality + in- 
hospital myocardial reinfarction + in-hospital refractory ischemia. 
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Conclusions: The present study implies that hs-CRP is a strong predictors of IT effec- 
tiveness whilst elevated plasma cTnl values may reflect the preceding myocardial macro- 
sis (strong asswatlon with prehospital delay). Fb and Lp(a) are not associated with 
thrombolysis outcome. Acute inflammatory reaction at the culprit artery may be responsi- 
ble for the fail of IT in pts wth high CRP. 
Background. In most patients (pts) with acute myocardial infarction (Ml), there IS consid- 
erable improvement of left ventricular function (LVF) after primary angioplasty (PA), pre- 
sumably by recovery of stunned myocardium. However, the impact of multivessel 
disease (MVD) on this process is largely unknown. 
Methods. To determine the impact of MVD and other clinical variables on the recovery of 
LVF we reviewed the data of 1702 pts with acute MI treated with PA. Pts were catego- 
rized in one- two- or three vessel disease (I-. 2., 3.VD) based on the angiogram before 
PA. Radionuclide ejection fraction (EF) was assessed before discharge and after 6 
months. 
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Background: When compared with unfractionated heparin (UFH). co-therapy with enox- 
apar~n (ENOX) or abciximab (ABC) results in a reduction of ischemic complications after 
ST-elevation acute myocardlal infarctnon treated with tenecteplase (ASSENT-3; n=8095). 
The effect of these new co-theraples on outcome after urgent percutaneous coronary 
interventions (PCI) is not known. Methods: Clinical outcomes after urgent PCI in the 
ASSENT-3 trial (n=716, 11.7%) were compared using Cox regression analysis including 
propensity scores and the timing of the event. Results: Results are shown in Table 1. 
Fewer ENOX and ABC treated patients needed urgent PCI compared with UFH (242/ 
2037 (11.9%) and 182/2009 (9.1%) vs. 292/2035 (14.3%); pcO.0001). Incidence of 
ischemlc events after urgent PCI was low and no significant differences between the 
treatments were seen, although there was a trend towards worse outcome with ABC. 
The incidence of non-cerebral major bleeding complications was significantly higher in 
the ABC arm compared with the UFH arm, while there was a modest increase with 
ENOX. Although total puncture-related bleeding rates were amilar, more major ones 
were seen with ENOX. The use of additional UFH during PCI was similar in the 3 groups 
(88% for ENOX, 71% for ABC and 71% for UFH). Conclusions: Although fewer patients 
needed urgent PCI after co-therapy with ABC and ENOX, clinical outcomes were less 
favorable I” this selected population, especially with ABC. 
Results. Serial EF was awlable in 575 pts: 278 pts (48%) had I-VD, 164 pts (28%) 2- 
VD and 133 (23%) 3-VD. 
Pts with MVD were older (age 56+11, 80*11 and 64+10 yrs in 1- 2- and 3.VD, respec- 
tively, pc.001) and more often had previous MI (5% 11% and 23%, pc.001). Anterior MI 
was less frequent in MVD (53%, 43% and 39%, p=.O22). There was no significant differ- 
ence in the prevalence of diabetes (8%. 10% and 8%, p=.298) or procedural wccess 
(96%, 96% and 92%. ~~202). 
Improvement of EF between discharge and 6 months decreased with more extensive 
coronary artery disease (CAD)(table). 
After correction for age, diabetes, previous Ml, infarct size and location, the extent of 
CAD remained a significant adverse predictor of recovery of LVF. 
Conclusion. Recovery of LVF after PA is impaired by more extensive CAD. This effect 
appears independent of other well known determinants of LVF after MI. 
EF before discharge and after 6 months in pts wth MVD 
EF predischarge (%) 
EF 6 months (%) 
Difference(%) 
Rel. difference(%) 
1 VD 
44*11 
48+10 
3.7*7.3 
11*21 
2VD 
45rll 
47*11 
1.8i7.6 
6+22 
3VD 
43ill 
44*12 
0.7~7.2 
3+20 
p-value 
0.480 
0.001 
< 0.001 
0.001 
1191-50 Patency of Infarct Related Artery Influences In-Hospital 
Outcome of Patients Undergoing Facilitated 
Endpunt 
Death at 30 days 
Remfarction 
Refractory lschemta 
Composite efficacy 
endpoint * 
Major bleeds 
Bleeds at arterial 
puncture site 
Major bleeds at arterial 
puncture site 
Label 
ENOX vs. 
UFH 
ABC vs. 
UFH 
ENOX vs. 
UFH 
ABC “s. 
UFH 
ENOX vs. 
UFH 
ABC vs. 
UFH 
ENOX vs. 
UFH 
ABC vs. 
UFH 
ENOX vs. 
UFH 
ABC vs. 
UFH 
ENOX vs. 
UFH 
ABC vs. 
UFH 
ENOX vs. 
UFH 
ABC vs. 
UFH 
Table I 
n/N (%) HR (95% Cl); 
P-value 
13/242 (5.37%) vs. 13/ 1.11 (0.51. 
292 (4.45%) 2.42); 0.80 
15/182 (8.24%) vs. 131 1.85 (0.87- 
292 (4.45%) 3.94); 0.11 
6 / 242 (2.48%) vs. 8/292 1.07 (0.37. 
(2.74%) 3.05); 0.90 
7 / 182 (3.85%) vs. 8/292 2.09 (0.76- 
(2.74%) 7.81); 0.16 
4 i 242 (1.65%) vs. 11292 4.35 (0.49. 
(0.34%) 38.9): 0.19 
2 / 182 (1.10%) vs. 11292 3.09 (0.28- 
(0.34%) 34.5); 0.36 
13/242 (5.37%) vs. 16/ 0.95 (0.46. 
292 (5.48%) 1 98); 0.90 
17/182 (9.34%) vs. 161 1.59 (0.80. 
292 (5.48%) 3.17); 0.18 
171242 (7.02%) vs. 101 1.67 (0.72. 
292 (3.44%) 3.90); 0.23 
161182 (8.79%) vs. IO/ 2.87 (1.26- 
292 (3.44%) 6.58); 0.01 
57/242 (23.55%) vs. 57/ 1.17 (0.80- 
292 (19.52%) 1.71); 0.42 
34/182 (18.88%) vs. 57/ 0.94 (0.60~ 
292 (19.52%) 1.45); 0.76 
101242 (4.13%) vs. 5/292 2.54 (0.78~ 
(1.71%) 8.42); 0.13 
4 / 182 (2.20%) vs. 5/292 1.29 (0.32- 
(1 71%) 5.29); 0.72 
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Background: Patency of infarct related artery (IRA) before primary percutaneous coro- 
nary intervention (PCI) for acute myocardial infarction (AMI) is associated with better out- 
come. However, there IS no data on the influence of IRA patency before PCI on 
myocardial perfusion and in-hospital outcome of patients (pts) undergoing facilitated PCI. 
Methods: 198 non shock pts with AMI admitted to remote hospitals were enrolled if they 
presented within 12 hrs of chest pain onset. were eligible for thrombolysis and if the 
anticipated transfer time to catheterization laboratory was > 90 min. All pts received i.v. 
bolus of 60Ulkg heparin, 15 mg alteplase and 0.25 mglkg abciximab at the remote hospl- 
tal and were immediately transferred to anglography. Infusion of alteplase (35mg/60 min) 
and abclximab (0.125 uglkglmin) was contmued during transfer. Results: Start of lythic 
therapy to angiography time was 126+51 min. At baseline angiography occluded IRA 
(TIMI 0+1) was found in 14% of pts (group 1) and patent IRA (TIMI 2+3) in 86% of pts. 
(group 2). Immediate PCI was performed I” all patients in group 1, and in 75% of pts in 
group 2. Frequency of TIMI- flow after PCI, myocardlal perfusion grade (MPG-3) after 
PCI and in-hospital MACE (death, re-AMI. re-PCI) for both groups are shown in the 
Table. Conclusions: This combined lythic therapy resulted I” 86% of opened IRA before 
PCI. Patients with occluded IRA at baseline had worse myocardlal perfusion and in-hos- 
pital clinical outcome even after successful PCI. 
